Assessing the Impact of the Absence of Detrusor Muscle in Ta Low-grade Urothelial Carcinoma of the Bladder on Recurrence-free Survival

被引:19
|
作者
Mastroianni, Riccardo [1 ,2 ]
Brassetti, Ado [1 ]
Krajewski, Wojciech [3 ]
Zdrojowy, Romuald [3 ]
Al Salhi, Yazan [4 ]
Anceschi, Umberto [1 ]
Bove, Alfredo Maria [1 ]
Carbone, Antonio [4 ]
De Nunzio, Cosimo [5 ]
Fuschi, Andrea [4 ]
Ferriero, Mariaconsiglia [1 ]
Nacchia, Antonio [5 ]
Pastore, Antonio Luigi [4 ]
Tema, Giorgia [5 ]
Tuderti, Gabriele [1 ]
Gallucci, Michele [2 ]
Simone, Giuseppe [1 ]
机构
[1] Regina Elena Inst Canc Res, Dept Urol, Via Elio Chianesi 53, I-00154 Rome, RM, Italy
[2] Sapienza Univ, Dept Urol, Rome, Italy
[3] Wroclaw Med Univ, Dept Urol & Urol Oncol, Wroclaw, Poland
[4] Sapienza Univ ICOT, Dept Medico Surg Sci & Biotechnol, Urol Unit, Latina, Italy
[5] St Andrea Hosp, Dept Urol, Rome, Italy
来源
EUROPEAN UROLOGY FOCUS | 2021年 / 7卷 / 06期
关键词
Non-muscle-invasive bladder cancer; Detrusor muscle; Transurethral resection of the bladder; Recurrence-free survival; Low-risk bladder cancer; Intermediate-risk bladder cancer; Low-grade bladder cancer; TRANSURETHRAL RESECTION; EUROPEAN ORGANIZATION; INDIVIDUAL PATIENTS; PROGNOSTIC-FACTORS; STAGE TA; CANCER; RISK; CLASSIFICATION; PROGRESSION; NEOPLASMS;
D O I
10.1016/j.euf.2020.08.007
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Obtaining detrusor muscle (DM) in transurethral resection of bladder tumor (TURBt) specimen is considered a surrogate marker of resection quality. However, evidence was principally investigated in high-risk tumors. Therefore, DM sampling for low-grade (LG) urothelial carcinoma (UC) remains poorly investigated and certainly requires further investigation. Objective: To assess whether the absence of DM in TURBt specimen has a negative impact on recurrence-free survival (RFS) in patients with a Ta LG UC. Design, setting, and participants: A multicenter TURBt database was queried for "LG, Ta, UC of the bladder." All patients treated between 1996 and 2018 with tumor grade assessed according to both 1973 World Health Organization and 2004 WHO/International Society of Urological Pathology grading classifications and with a minimum follow-up of 1 yr were included. Patients with a previous history of high-grade UC, upper urinary tract UC, or bladder tumor differentiations other than UC were excluded. Intervention: TURBt. Outcome measurements and statistical analysis: Baseline demographic, clinical, and pathologic data were analyzed. The European Organization for Research and Treatment of Cancer (EORTC) risk group was recorded. Kaplan-Meier analysis was performed to assess the predictive role of clinical and pathologic data for RFS. Univariable and multivariable Cox regression analyses were performed to identify the predictors of recurrence. Results and limitations: Overall, 521 patients were included. At Kaplan-Meier analysis, the low-risk cohort displayed significantly higher RFS than the intermediate-risk cohort (1-yr RFS 87% vs 79%; log-rank p = 0.007). At univariable Cox regression analysis, only gender, multiple tumors, tumor diameter >= 3 cm, and EORTC risk group were significant predictors of recurrence. Absence of DM had no impact on RFS. Multivariable Cox regression analysis confirmed gender and EORTC risk group as independent predictors of recurrence. Conclusions: Absence of DM in TURBt specimen has negligible role in RFS of patients with Ta LG tumors of the bladder. Patient summary: In this study, we assessed the role that detrusor muscle (DM) in transurethral resection of bladder tumor specimen has in recurrence-free survival, in patients with a Ta low-grade urothelial carcinoma of the bladder. Absence of DM has no impact on tumor recurrence; therefore, it does not require additional attention. (C) 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1324 / 1331
页数:8
相关论文
共 50 条
  • [1] ASSESSING THE IMPACT OF ABSENCE OF DETRUSOR MUSCLE IN TA-LG UROTHELIAL CARCINOMA OF THE BLADDER ON RECURRENCE FREE SURVIVAL
    Mastroianni, Riccardo
    Brassetti, Aldo
    Al Salhi, Yazan
    Anceschi, Umberto
    Bove, Alfredo
    Carbone, Antonio
    De Nunzio, Cosimo
    Fuschi, Andrea
    Ferriero, Mariaconsiglia
    Nacchia, Antonio
    Pastore, Antonio
    Tema, Giorgia
    Tuderti, Gabriele
    Simone, Giuseppe
    JOURNAL OF UROLOGY, 2020, 203 : E1073 - E1074
  • [2] Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
    Oosterlinck, W
    Solsona, E
    Akaza, H
    Busch, C
    Goebell, PJ
    Malmström, PU
    Özen, H
    Sved, P
    UROLOGY, 2005, 66 (6A) : 75 - 89
  • [3] Development of a predictive model for recurrence-free survival in pTa low-grade bladder cancer
    Daza, Jorge
    Grauer, Ralph
    Chen, Sophie
    Lavalle, Etienne
    Razdan, Shirin
    Dey, Linda
    Steineck, Gunnar
    Renstrom-Koskela, Lotta
    Li, Qiang
    Hussein, Ahmed A.
    Mehrazin, Reza
    Waingankar, Nikhil
    Guru, Khurshid
    Wiklund, Peter
    Sfakianos, John P.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 256.e9 - 256.e15
  • [4] No impact of detrusor muscle absence in pTaHG urothelial bladder carcinoma first TURB
    Tissot, G.
    Regnier, S.
    Moschini, M.
    Afferi, L.
    D'Andrea, D.
    Krajewski, W.
    Soria, F.
    Roumiguie, M.
    Verhoest, G.
    Alvarez Maestro, M.
    Mattei, A.
    Montorsi, F.
    Shariat, S.
    Gontero, P.
    Xylinas, E.
    EUROPEAN UROLOGY, 2024, 85 : S388 - S388
  • [5] DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL FOR RECURRENCE-FREE SURVIVAL IN PTA LOW-GRADE BLADDER CANCER
    Daza, Jorge
    Grauer, Ralph
    Chen, Sophie
    Lavallee, Etienne
    Razdan, Shirin
    Dey, Linda
    Steineck, Gunnar
    Li, Qiang
    Ahmed, Aly
    Mehrazin, Reza
    Waingankar, Nikhil
    Guru, Khurshid
    Wiklund, Peter
    Sfakianos, John
    JOURNAL OF UROLOGY, 2022, 207 (05): : E1009 - E1009
  • [6] Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma
    Milojevic, Bogomir
    Janicic, Aleksandar
    Milojevic, Isidora Grozdic
    Grubor, Nikola
    Bumbasirevic, Uros
    Radovanovic, Milan
    Radisavcevic, Djordje
    Jovanovic, Darko
    Sretenovic, Milan
    Durutovic, Otas
    Grujicic, Sandra Sipetic
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2538 - 2544
  • [7] Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract Urothelial Carcinoma
    Bogomir Milojevic
    Aleksandar Janicic
    Isidora Grozdic Milojevic
    Nikola Grubor
    Uros Bumbasirevic
    Milan Radovanovic
    Djordje Radisavcevic
    Darko Jovanovic
    Milan Sretenovic
    Otas Durutovic
    Sandra Sipetic Grujicic
    Annals of Surgical Oncology, 2024, 31 : 2538 - 2544
  • [8] DAX-1 expression is associated with decreased recurrence-free survival in lymph node negative low-grade prostate carcinoma
    Amrikachi, M
    Li, R
    Weigel, N
    Wheeler, TM
    Frolov, A
    Ayala, G
    MODERN PATHOLOGY, 2003, 16 (01) : 140A - 140A
  • [9] Predicting factors for recurrence in low-grade Ta primary bladder tumours
    Molina Escudero, R.
    Alvarez Ardura, M.
    Ripalda Ferretti, E.
    Crespo Martinez, L.
    Gonzalez Avila, N.
    Dorado Valentin, M.
    Paez Borda, A.
    ARCHIVOS ESPANOLES DE UROLOGIA, 2014, 67 (06): : 541 - 548
  • [10] DAX-1 expression is associated with decreased recurrence-free survival in lymph node negative low-grade prostate carcinoma
    Amrikachi, M
    Li, R
    Weigel, N
    Wheeler, TM
    Frolov, A
    Ayala, G
    LABORATORY INVESTIGATION, 2003, 83 (01) : 140A - 140A